Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Cholestatic liver injury associated with dietary supplements: a report of five cases in active duty service members.

Peterson BR, DeRoche TC, Huber AR, Shields WW.

Mil Med. 2013 Oct;178(10):e1168-71. doi: 10.7205/MILMED-D-13-00228.

PMID:
24083935
2.

Cholestatic liver injury secondary to artemisinin.

Kumar S.

Hepatology. 2015 Sep;62(3):973-4. doi: 10.1002/hep.27900. Epub 2015 Jul 22. No abstract available.

PMID:
25980398
3.

A Case Report of Supplement-Induced Hepatitis in an Active Duty Service Member.

Brazeau MJ, Castaneda JL, Huitron SS, Wang J.

Mil Med. 2015 Jul;180(7):e844-6. doi: 10.7205/MILMED-D-14-00654.

PMID:
26126259
4.

[Clinical and pathological features in 138 cases of drug-induced liver injury].

Lai RT, Wang H, Gui HL, Ye MZ, Dai WJ, Xiang XG, Zhao GD, Wang WJ, Xie Q.

Zhonghua Gan Zang Bing Za Zhi. 2012 Mar;20(3):185-9. doi: 10.3760/cma.j.issn.1007-3418.2012.03.009. Chinese.

PMID:
22475136
5.

[Clinic-epidemiological significance of drug hepatotoxicity in liver disease consultation].

Jmelnitzky AC, Guidi M, Bologna A, Viola M, Soccini C, Barbero R, Belloni P, Apraiz M.

Acta Gastroenterol Latinoam. 2000;30(2):77-84. Spanish.

PMID:
10925723
6.

Flucloxacillin induced delayed cholestatic hepatitis.

Miros M, Kerlin P, Walker N, Harris O.

Aust N Z J Med. 1990 Jun;20(3):251-3.

PMID:
2372276
7.

Review of liver injury associated with dietary supplements.

Stickel F, Kessebohm K, Weimann R, Seitz HK.

Liver Int. 2011 May;31(5):595-605. doi: 10.1111/j.1478-3231.2010.02439.x. Epub 2011 Jan 11. Review.

PMID:
21457433
8.

Leflunomide-induced acute hepatitis.

Sevilla-Mantilla C, Ortega L, Agúndez JA, Fernández-Gutiérrez B, Ladero JM, Díaz-Rubio M.

Dig Liver Dis. 2004 Jan;36(1):82-4.

PMID:
14971821
9.

Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements.

Bonkovsky HL, Kleiner DE, Gu J, Odin JA, Russo MW, Navarro VM, Fontana RJ, Ghabril MS, Barnhart H, Hoofnagle JH; U.S. Drug Induced Liver Injury Network Investigators.

Hepatology. 2017 Apr;65(4):1267-1277. doi: 10.1002/hep.28967. Epub 2017 Feb 7.

PMID:
27981596
10.

Hepatotoxicity associated with dietary supplements containing anabolic steroids.

Kafrouni MI, Anders RA, Verma S.

Clin Gastroenterol Hepatol. 2007 Jul;5(7):809-12. Epub 2007 May 16.

PMID:
17509944
11.

Herbal does not mean innocuous: ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife products.

Schoepfer AM, Engel A, Fattinger K, Marbet UA, Criblez D, Reichen J, Zimmermann A, Oneta CM.

J Hepatol. 2007 Oct;47(4):521-6. Epub 2007 Jul 24.

PMID:
17692989
12.

Severe Acute Hepatocellular Injury Attributed to OxyELITE Pro: A Case Series.

Heidemann LA, Navarro VJ, Ahmad J, Hayashi PH, Stolz A, Kleiner DE, Fontana RJ.

Dig Dis Sci. 2016 Sep;61(9):2741-8. doi: 10.1007/s10620-016-4181-7. Epub 2016 May 3. Erratum in: Dig Dis Sci. 2016 Oct 6;:.

13.

Hepatotoxicity due to hydroxycut: a case series.

Fong TL, Klontz KC, Canas-Coto A, Casper SJ, Durazo FA, Davern TJ 2nd, Hayashi P, Lee WM, Seeff LB.

Am J Gastroenterol. 2010 Jul;105(7):1561-6. doi: 10.1038/ajg.2010.5. Epub 2010 Jan 26.

14.

Cholestatic hepatitis related to use of irbesartan: a case report and a literature review of angiotensin II antagonist-associated hepatotoxicity.

Andrade RJ, Lucena MI, Fernández MC, Vega JL, García-Cortés M, Casado M, Guerrero-Sanchez E, Pulido-Fernandez F.

Eur J Gastroenterol Hepatol. 2002 Aug;14(8):887-90. Review.

PMID:
12172412
15.

Chaparral-associated hepatotoxicity.

Sheikh NM, Philen RM, Love LA.

Arch Intern Med. 1997 Apr 28;157(8):913-9.

PMID:
9129552
16.

Phenytoin-induced toxic cholestatic hepatitis in a patient with skin lesions: case report.

Altuntaş Y, Oztürk B, Erdem L, Günes G, Karul S, Uçak S, Sengül A.

South Med J. 2003 Feb;96(2):201-3.

PMID:
12630649
17.

Severe hepatotoxicity caused by a methasteron-containing performance-enhancing supplement.

Singh V, Rudraraju M, Carey EJ, Byrne TJ, Vargas HE, Williams JE, Balan V, Douglas DD, Rakela J.

J Clin Gastroenterol. 2009 Mar;43(3):287. doi: 10.1097/MCG.0b013e31815a5796. No abstract available.

PMID:
18813027
18.

[Hepatotoxicity associated with the use of Herbalife].

Jóhannsson M, Ormarsdóttir S, Olafsson S.

Laeknabladid. 2010 Mar;96(3):167-72. Icelandic.

PMID:
20197595
19.

Experience with OxyELITE pro and acute liver injury in active duty service members.

Foley S, Butlin E, Shields W, Lacey B.

Dig Dis Sci. 2014 Dec;59(12):3117-21. doi: 10.1007/s10620-014-3221-4. Epub 2014 Jun 12.

PMID:
24916713
20.

 Hepatotoxicity associated with dietary energy supplements: use and abuse by young athletes.

Avelar-Escobar G, Méndez-Navarro J, Ortiz-Olvera NX, Castellanos G, Ramos R, Gallardo-Cabrera VE, Vargas-Alemán Jde J, Díaz de León O, Rodríguez EV, Dehesa-Violante M.

Ann Hepatol. 2012 Jul-Aug;11(4):564-9.

Supplemental Content

Support Center